{"count": 1, "results": [{"_id": "30651718", "pmid": 30651718, "pmcid": "PMC6330460", "title": "Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway", "journal": "Cancer Cell Int", "authors": ["Liu Y", "Hu X", "Shan X", "Chen K", "Tang H"], "date": "2019-01-11T00:00:00Z", "doi": "10.1186/s12935-019-0732-2", "meta_date_publication": "2019", "meta_volume": "19", "meta_issue": "", "meta_pages": "13", "score": 50035.223, "text_hl": "...@<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@HCC@@@", "citations": {"NLM": "Liu Y, Hu X, Shan X, Chen K, Tang H. Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway Cancer Cell Int. 2019;19():13. PMID: 30651718", "BibTeX": "@article{30651718, title={Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway}, author={Liu Y and Hu X and Shan X and Chen K and Tang H}, journal={Cancer Cell Int}, volume={19}, pages={13}}"}}]}